Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) CEO Jitendra Mohan sold 171,064 shares of the business’s stock in a transaction that occurred on Thursday, November 21st. The stock was sold at an average price of $103.53, for a total value of $17,710,255.92. Following the transaction, the chief executive officer now directly owns 628,895 shares in the company, valued at approximately $65,109,499.35. This trade represents a 21.38 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Jitendra Mohan also recently made the following trade(s):
- On Friday, October 11th, Jitendra Mohan sold 47,667 shares of Astera Labs stock. The stock was sold at an average price of $70.26, for a total value of $3,349,083.42.
Astera Labs Trading Down 1.7 %
NASDAQ ALAB opened at $105.48 on Wednesday. The company has a 50 day moving average of $72.05 and a 200-day moving average of $60.30. Astera Labs, Inc. has a 1-year low of $36.22 and a 1-year high of $113.85.
Institutional Investors Weigh In On Astera Labs
Institutional investors and hedge funds have recently bought and sold shares of the company. Sei Investments Co. acquired a new stake in Astera Labs during the first quarter worth about $952,000. Vanguard Group Inc. bought a new stake in shares of Astera Labs during the 1st quarter worth approximately $127,268,000. Price T Rowe Associates Inc. MD acquired a new stake in shares of Astera Labs during the 1st quarter worth approximately $44,514,000. Janus Henderson Group PLC bought a new position in Astera Labs in the first quarter valued at approximately $20,025,000. Finally, Rokos Capital Management LLP acquired a new position in Astera Labs during the first quarter valued at approximately $1,484,000.
Analyst Ratings Changes
A number of equities research analysts recently weighed in on ALAB shares. JPMorgan Chase & Co. increased their price target on Astera Labs from $70.00 to $110.00 and gave the company an “overweight” rating in a research note on Tuesday, November 5th. Citigroup began coverage on shares of Astera Labs in a research report on Monday, November 18th. They issued a “buy” rating and a $120.00 price objective on the stock. Needham & Company LLC reaffirmed a “buy” rating and set a $65.00 target price on shares of Astera Labs in a report on Wednesday, October 9th. Roth Mkm upped their price target on shares of Astera Labs from $80.00 to $105.00 and gave the company a “buy” rating in a research note on Tuesday, November 5th. Finally, Morgan Stanley raised their price objective on shares of Astera Labs from $74.00 to $94.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 5th. Twelve analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of $94.67.
View Our Latest Research Report on ALAB
About Astera Labs
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
See Also
- Five stocks we like better than Astera Labs
- Earnings Per Share Calculator: How to Calculate EPS
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- Learn Technical Analysis Skills to Master the Stock Market
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- High Flyers: 3 Natural Gas Stocks for March 2022
- Why Amazon Shares May Never Trade Below $200 Again
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.